Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
Representatives from the two companies emphasized that its effectiveness is still being validated. At this stage, it is to be used for research purposes and not as a diagnostic tool.
A tech giant is offering a free hand to healthcare experts working in various fields that could be tapping tireless AI rather than overworked humans to answer questions from the general public on COVID-19.
The images are rendered from CT scans and allow viewers to navigate the lungs in 360-degree tours, as demonstrated in a video podcast posted by George Washington University Hospital.
A disease that hits most people mildly but some very hard—and so wreaks havoc with its unpredictability among the infected—would seem a good target for AI’s predictive prowess.
Researchers in South Korea have shown that AI trained on photos of both Asian and Caucasian patients can help dermatologists more accurately diagnose many diseases and disorders of the skin in both subpopulations.
A healthcare AI company has spotted several unexpected, off-label drug combinations that may do the job against COVID-19. In any case, the company is offering its complete AI toolkit free of charge to drug developers working on COVID treatments.
Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.
The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals.
As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”
